Strain Information | |
|---|---|
| Image | |
| BRC No. | RBRC11362 |
| Type | Targeted Mutation |
| Species | Mus musculus |
| Strain name | B6;129-Sall2<tm1Ryn> |
| Former Common name | Sall2 KO |
| H-2 Haplotype | |
| ES Cell line | E14.1 [129P2/OlaHsd] |
| Background strain | |
| Appearance | |
| Strain development | Deposited by Ryuichi Nishinakamura, Kumamoto University in 2021. This strain was generated using E14.1 (ES Cell) derived from 129P2/OlaHsd. Mice were further backcrossed to C57BL/6J once. |
| Strain description | Sall2 knockout mice. |
| Colony maintenance | |
| References | Zinc finger protein sall2 is not essential for embryonic and kidney development. Sato A, Matsumoto Y, Koide U, Kataoka Y, Yoshida N, Yokota T, Asashima M, Nishinakamura R Mol. Cell. Biol., 23(1):62-9 (2003). 12482961 |
Health Report | |
|---|---|
| Examination Date / Room / Rack | |
Gene | |||||||
|---|---|---|---|---|---|---|---|
| Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
| Sall2 MGI:1354373 | spalt like transcription factor 2 | 14 | Sall2<tm1Ryn> MGI:2448237 | targeted mutation 1, Ryuichi Nishinakamura | |||
| neo | neomycin resistance gene (E. coli) | 14 | mouse phosphoglycerate kinase promoter (PGK promoter) | ||||
Phenotype | |
|---|---|
| Phenotype annotation from literatures by Mammalian phenotype ontology | |
| Detailed phenotype data | |
Ordering Information | |
|---|---|
| Donor DNA | マウス PGK プロモーター, 大腸菌 Neo 耐性遺伝子 |
| Research application | Developmental Biology Research |
| Specific Term and Conditions | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Mol Cell Biol. 2003 Jan;23(1):62-9.In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. For use of the BIOLOGICAL RESOURCE by a for-profit organization or commercial users, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. RECIPIENT must contact the DEPOSITOR in the case of a application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
| Depositor | Ryuichi Nishinakamura (Kumamoto University) |
| Strain Status | Frozen embryos |
| Strain Availability | |
| Additional Info. | Necessary documents for ordering: |
BRC mice in Publications |
|---|
| No Data |